scholarly article | Q13442814 |
P50 | author | Imran N. Mungrue | Q55909082 |
P2093 | author name string | Robert Gros | |
Duncan J Stewart | |||
Jagdish Butany | |||
Richard Schulz | |||
Mansoor Husain | |||
Tamas Csont | |||
Xiaomang You | |||
Azar Azad | |||
Asif Pirani | |||
P2860 | cites work | Nitric oxide synthase complexed with dystrophin and absent from skeletal muscle sarcolemma in Duchenne muscular dystrophy | Q24307833 |
Nitric oxide synthases in mammals | Q24528695 | ||
Tight control of gene expression in mammalian cells by tetracycline-responsive promoters | Q24564850 | ||
A novel genetic pathway for sudden cardiac death via defects in the transition between ventricular and conduction system cell lineages | Q28510409 | ||
The role of neutrophils in myocardial ischemia-reperfusion injury | Q33806223 | ||
Interactions between NO and reactive oxygen species: pathophysiological importance in atherosclerosis, hypertension, diabetes and heart failure | Q33847589 | ||
Inducible nitric oxide synthase gene expression in the brain during systemic inflammation | Q34377295 | ||
Verapamil ameliorates the clinical and pathological course of murine myocarditis | Q35609065 | ||
Beneficial effects and improved survival in rodent models of septic shock with S-methylisothiourea sulfate, a potent and selective inhibitor of inducible nitric oxide synthase | Q35986312 | ||
Complete heart block and sudden death in mice overexpressing calreticulin | Q36166973 | ||
Superoxide and peroxynitrite generation from inducible nitric oxide synthase in macrophages | Q36244224 | ||
Superoxide generation by endothelial nitric oxide synthase: the influence of cofactors | Q36253833 | ||
Conditional and targeted overexpression of vascular chymase causes hypertension in transgenic mice | Q36311525 | ||
Myocardial capillary permeability for small hydrophilic indicators during normal physiological conditions and after ischemia and reperfusion | Q36949763 | ||
Role of nitric oxide in obesity-induced beta cell disease | Q37369915 | ||
Inducible nitric oxide synthase: what difference does it make? | Q37374566 | ||
Purification and characterization of the cytokine-induced macrophage nitric oxide synthase: an FAD- and FMN-containing flavoprotein | Q37587741 | ||
Role of transcription factor NF-kappa B/Rel in induction of nitric oxide synthase | Q38311029 | ||
Nitric oxide in cardiovascular diseases | Q40405159 | ||
NOS2 mediates opposing effects in models of acute and chronic cardiac rejection: insights from NOS2-knockout mice | Q42136278 | ||
Induction and potential biological relevance of a Ca(2+)-independent nitric oxide synthase in the myocardium | Q42712096 | ||
Cardiac-specific overexpression of inducible nitric oxide synthase does not result in severe cardiac dysfunction | Q43851357 | ||
Induction of nitric oxide synthase in the human cardiac allograft is associated with contractile dysfunction of the left ventricle | Q45096844 | ||
Superoxide dismutase reduces reperfusion arrhythmias but fails to salvage regional function or myocardium at risk in conscious dogs | Q46646164 | ||
Conduction disturbances and increased atrial vulnerability in Connexin40-deficient mice analyzed by transesophageal stimulation. | Q51469223 | ||
Requirement for transcription factor IRF-1 in NO synthase induction in macrophages. | Q52507356 | ||
Histochemical methods for separate, consecutive and simultaneous demonstration of acetylcholinesterase and norepinephrine in cryostat sections. | Q54516964 | ||
Exacerbation of reperfusion arrhythmias by sudden oxidant stress | Q68865890 | ||
Targeting of transgene expression to the vascular endothelium of mice by homologous recombination at the thrombomodulin locus | Q70934675 | ||
Expression of inducible nitric oxide synthase in human heart failure | Q71129305 | ||
Conditional transgene expression in the heart | Q71590968 | ||
Cytokine-inducible nitric oxide synthase (iNOS) expression in cardiac myocytes. Characterization and regulation of iNOS expression and detection of iNOS activity in single cardiac myocytes in vitro | Q71656579 | ||
Altered responses to bacterial infection and endotoxic shock in mice lacking inducible nitric oxide synthase | Q71694221 | ||
S-methylisothiourea inhibits inducible nitric oxide synthase and improves left ventricular performance after acute myocardial infarction | Q71700654 | ||
Nitric oxide synthase activities in human myocardium | Q72067146 | ||
Decreased myocardial nNOS, increased iNOS and abnormal ECGs in mouse models of Duchenne muscular dystrophy | Q73092279 | ||
Effects of nitric oxide synthase inhibition on Basal function and the force-frequency relationship in the normal and failing human heart in vivo | Q77130008 | ||
Nitric oxide and inflammatory bowel diseases | Q77586534 | ||
Attenuated acute cardiac rejection in NOS2 -/- recipients correlates with reduced apoptosis | Q78171893 | ||
P433 | issue | 6 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | overexpression | Q61643320 |
P304 | page(s) | 735-743 | |
P577 | publication date | 2002-03-01 | |
P1433 | published in | Journal of Clinical Investigation | Q3186904 |
P1476 | title | Cardiomyocyte overexpression of iNOS in mice results in peroxynitrite generation, heart block, and sudden death | |
P478 | volume | 109 |
Q36870802 | Absence of cytoglobin promotes multiple organ abnormalities in aged mice |
Q35113704 | Activation of the poly(ADP-ribose) polymerase pathway in human heart failure. |
Q57570889 | Additional lack of iNOS attenuates diastolic dysfunction in aged ET-1 transgenic miceThis article is one of a selection of papers published in the special issue (part 1 of 2) on Forefronts in Endothelin |
Q26745608 | Altered Nitric Oxide System in Cardiovascular and Renal Diseases |
Q36841087 | An Angiotensin receptor blocker prevents arrhythmogenic left atrial remodeling in a rat post myocardial infarction induced heart failure model |
Q97074413 | An Interplay Between MRTF-A and the Histone Acetyltransferase TIP60 Mediates Hypoxia-Reoxygenation Induced iNOS Transcription in Macrophages |
Q37645436 | Angiogenesis in the atherosclerotic plaque. |
Q28744457 | Arrhythmia and neuronal/endothelial myocyte uncoupling in hyperhomocysteinemia |
Q36851491 | Atherosclerosis following renal injury is ameliorated by pioglitazone and losartan via macrophage phenotype. |
Q99238451 | BRG1 Activates PR65A Transcription to Regulate NO Bioavailability in Vascular Endothelial Cells |
Q37200514 | Baroreflex activation for the treatment of heart failure |
Q44882004 | Beneficial effects of olmesartan, a novel angiotensin II receptor type 1 antagonist, upon acute autoimmune myocarditis |
Q36805511 | Biphasic effect of SIN-1 is reliant upon cardiomyocyte contractile state |
Q40250067 | Carbon monoxide increases inducible NOS expression that mediates CO-induced myocardial damage during ischemia-reperfusion |
Q34146899 | Cardiac function is preserved following 4 weeks of voluntary wheel running in a rodent model of chronic kidney disease |
Q46234303 | Cardiac transgenesis with the tetracycline transactivator changes myocardial function and gene expression |
Q50073229 | Cardiomyocyte-targeted overexpression of the coxsackie-adenovirus receptor causes a cardiomyopathy in association with beta-catenin signaling. |
Q57294310 | Cardioprotection of benzolamide in a regional ischemia model: Role of ENOS/NO |
Q41789139 | Cardioprotective effects of 3-methyl-1-phenyl-2-pyrazolin-5-one (MCI-186), a novel free radical scavenger, on acute autoimmune myocarditis in rats |
Q43972291 | Cardioprotective effects of nicorandil, a mitochondrial potassium channel opener against doxorubicin-induced cardiotoxicity in rats |
Q27335261 | Cardiovascular risks associated with low dose ionizing particle radiation |
Q51620699 | Cellular expression of renal, cardiac and pulmonary inducible nitric oxide synthase in double-transgenic mice expressing human renin and angiotensinogen genes. |
Q37578136 | Chronic alcohol consumption disrupts myocardial protein balance and function in aged, but not adult, female F344 rats |
Q37835753 | Conflicting effects of nitric oxide and oxidative stress in chronic heart failure: potential therapeutic strategies |
Q42262267 | Contractile Activity Regulates Inducible Nitric Oxide Synthase Expression and NO(i) Production in Cardiomyocytes via a FAK-Dependent Signaling Pathway |
Q37344982 | Cox-2 Inhibition Protects against Hypoxia/Reoxygenation-Induced Cardiomyocyte Apoptosis via Akt-Dependent Enhancement of iNOS Expression |
Q34331352 | Decreased vascular lesion formation in mice with inducible endothelial-specific expression of protein kinase Akt |
Q42591255 | Deficiency of iNOS Does Not Prevent Isoproterenol-induced Cardiac Hypertrophy in Mice |
Q37085195 | Deletion of inducible nitric oxide synthase provides cardioprotection in mice with 2-kidney, 1-clip hypertension |
Q41933607 | Device-based autonomic modulation in arrhythmia patients: the role of vagal nerve stimulation |
Q36056243 | Differential modulation of nitric oxide synthases in aging: therapeutic opportunities. |
Q89861114 | Dose-Dependent Effects of Long-Term Administration of Hydrogen Sulfide on Myocardial Ischemia-Reperfusion Injury in Male Wistar Rats: Modulation of RKIP, NF-κB, and Oxidative Stress |
Q59192120 | Downregulation of connexin40 and increased prevalence of atrial arrhythmias in transgenic mice with cardiac-restricted overexpression of tumor necrosis factor |
Q33725534 | Dysautonomia due to reduced cholinergic neurotransmission causes cardiac remodeling and heart failure |
Q34652525 | Earliest changes in the left ventricular transcriptome postmyocardial infarction |
Q61937241 | Efectos del óxido nítrico sobre la función cardíaca |
Q50680134 | Effects of l-arginine and creatine administration on spatial memory in rats subjected to a chronic variable stress model. |
Q26851442 | Electrical vagus nerve stimulation for the treatment of chronic heart failure |
Q46360944 | Functional and Structural Assessment of the Effect of Human Umbilical Cord Blood Mesenchymal Stem Cells in Doxorubicin-Induced Cardiotoxicity |
Q36829373 | Gene therapy with iNOS provides long-term protection against myocardial infarction without adverse functional consequences |
Q52866707 | Genetic variations involved in sudden cardiac death and their associations and interactions. |
Q33967356 | Hypoxia-induced left ventricular dysfunction in myoglobin-deficient mice |
Q50141973 | Inducible NO Synthase mRNA Expression and Infiltration of Rats Myocardium with Inflammatory Cells in 2-4 Hours after Modeled Permanent Ischemia or Ischemia/Reperfusion |
Q36662476 | Inducible nitric oxide synthase deficiency protects the heart from systolic overload-induced ventricular hypertrophy and congestive heart failure. |
Q48960506 | Inducible nitric oxide synthase dimerization inhibitor prevents cardiovascular and renal morbidity in sheep with combined burn and smoke inhalation injury |
Q35945853 | Inducible nitric oxide synthase mediates DNA double strand breaks in Human T-Cell Leukemia Virus Type 1-induced leukemia/lymphoma. |
Q42936581 | Inhibition of Src kinase blocks high glucose-induced EGFR transactivation and collagen synthesis in mesangial cells and prevents diabetic nephropathy in mice. |
Q46438380 | Integrin stimulation-induced hypertrophy in neonatal rat cardiomyocytes is NO-dependent |
Q37091001 | Isoproterenol-induced heart failure in the rat is associated with nitric oxide-dependent functional alterations of cardiac function |
Q36194188 | Isothiocyanates ameliorate the symptom of heart dysfunction and mortality in a murine AIDS model by inhibiting apoptosis in the left ventricle |
Q33730630 | KMUP-1 attenuates isoprenaline-induced cardiac hypertrophy in rats through NO/cGMP/PKG and ERK1/2/calcineurin A pathways |
Q36148204 | Lack of inducible NO synthase reduces oxidative stress and enhances cardiac response to isoproterenol in mice with deoxycorticosterone acetate-salt hypertension |
Q43168787 | Local transient myocardial liposomal gene transfer of inducible nitric oxide synthase does not aggravate myocardial function and fibrosis and leads to moderate neovascularization in chronic myocardial ischemia in pigs |
Q36422429 | Low-dose radiation affects cardiac physiology: gene networks and molecular signaling in cardiomyocytes. |
Q46650368 | MCI-186 (edaravone), a novel free radical scavenger, protects against acute autoimmune myocarditis in rats |
Q35581624 | Macrophage polarization by angiotensin II-type 1 receptor aggravates renal injury-acceleration of atherosclerosis |
Q37881801 | Modulating endothelial nitric oxide synthase: a new cardiovascular therapeutic strategy |
Q36461910 | Modulation of myocardial contraction by peroxynitrite |
Q34424756 | Netrin-1 improves post-injury cardiac function in vivo via DCC/NO-dependent preservation of mitochondrial integrity, while attenuating autophagy |
Q34963358 | Nitric oxide and cardioprotection during ischemia-reperfusion |
Q37556067 | Nitric oxide and nitric oxide synthase isoforms in the normal, hypertrophic, and failing heart |
Q24645400 | Nitric oxide and peroxynitrite in health and disease |
Q35213988 | Nitric oxide control of cardiac function: is neuronal nitric oxide synthase a key component? |
Q36814343 | Nitric oxide homeostasis as a target for drug additives to cardioplegia |
Q43267893 | Nitric oxide inhibits endothelin-1-induced neonatal cardiomyocyte hypertrophy via a RhoA-ROCK-dependent pathway |
Q35765975 | Nitric oxide signaling and the regulation of myocardial function. |
Q48716302 | Nitric oxide synthase 2 and pressure-overload-induced left ventricular remodelling in mice |
Q37917873 | Nitric oxide synthase and cyclic GMP signaling in cardiac myocytes: from contractility to remodeling |
Q38196172 | Nitric oxide synthase regulation of cardiac excitation-contraction coupling in health and disease |
Q37697596 | Nitric oxide synthases in the pathogenesis of cardiovascular disease: lessons from genetically modified mice |
Q36145124 | Nitrosative stress and pharmacological modulation of heart failure |
Q92979698 | Nuclear factor-kB and nitric oxide synthases in red blood cells: good or bad in obesity? A preliminary study |
Q35086748 | Obligatory role of heat shock protein 90 in iNOS induction |
Q50263286 | Ouabain increases iNOS-dependent nitric oxide generation which contributes to the hypertrophic effect of the glycoside: possible role of peroxynitrite formation |
Q92884435 | PARP-1 controls NK cell recruitment to the site of viral infection |
Q35620925 | Particle Radiation-Induced Nontargeted Effects in Bone-Marrow-Derived Endothelial Progenitor Cells. |
Q37786421 | Pathophysiological relevance of NO signaling in the cardiovascular system: Novel insight from mice lacking all NO synthases |
Q36532454 | Pathophysiology of hypertension in the absence of nitric oxide/cyclic GMP signaling |
Q44133546 | Pharmacologic inhibition of poly(adenosine diphosphate-ribose) polymerase may represent a novel therapeutic approach in chronic heart failure |
Q91374427 | Potential targets for intervention against doxorubicin-induced cardiotoxicity based on genetic studies: a systematic review of the literature |
Q46820254 | Pressure overload-induced hypertrophy in transgenic mice selectively overexpressing AT2 receptors in ventricular myocytes |
Q37664269 | Profilin-1 promotes the development of hypertension-induced artery remodeling |
Q35112436 | Protective effects of chinese traditional medicine buyang huanwu decoction on myocardial injury |
Q94452440 | Protective role of endothelial calpain knockout in lipopolysaccharide-induced acute kidney injury via attenuation of the p38-iNOS pathway and NO/ROS production |
Q45042376 | Proteomic identification of 3-nitrotyrosine-containing rat cardiac proteins: effects of biological aging |
Q35165194 | Reactive oxygen species in cardiovascular disease. |
Q36403180 | Reciprocal regulation of airway rejection by the inducible gas-forming enzymes heme oxygenase and nitric oxide synthase |
Q37009925 | Regulation of DDAH1 as a Potential Therapeutic Target for Treating Cardiovascular Diseases |
Q35121079 | Regulation of Inducible Nitric Oxide Synthase (iNOS) and its Potential Role in Insulin Resistance, Diabetes and Heart Failure |
Q34963256 | Regulation of cardiac remodeling by nitric oxide: focus on cardiac myocyte hypertrophy and apoptosis |
Q36770499 | Relevance of nitric oxide for myocardial remodeling. |
Q34212330 | Resveratrol improves left ventricular diastolic relaxation in type 2 diabetes by inhibiting oxidative/nitrative stress: in vivo demonstration with magnetic resonance imaging |
Q39260228 | Role of nitric oxide in regulating aldose reductase activation in the ischemic heart |
Q55663138 | Role of oxidative-nitrosative stress and downstream pathways in various forms of cardiomyopathy and heart failure. |
Q36665083 | Sabiporide reduces ischemia-induced arrhythmias and myocardial infarction and attenuates ERK phosphorylation and iNOS induction in rats |
Q91651455 | Sinapic Acid Ameliorates Oxidative Stress, Inflammation, and Apoptosis in Acute Doxorubicin-Induced Cardiotoxicity via the NF-κB-Mediated Pathway |
Q35098436 | Synergism between arrhythmia and hyperhomo-cysteinemia in structural heart disease. |
Q33619488 | TNF-TNFR2/p75 signaling inhibits early and increases delayed nontargeted effects in bone marrow-derived endothelial progenitor cells |
Q34039748 | TRPV1 Activation Attenuates High-Salt Diet-Induced Cardiac Hypertrophy and Fibrosis through PPAR-δ Upregulation |
Q37221679 | Targeting of phospholamban by peroxynitrite decreases beta-adrenergic stimulation in cardiomyocytes |
Q46811876 | Telmisartan attenuates myocardial apoptosis induced by chronic intermittent hypoxia in rats: modulation of nitric oxide metabolism and inflammatory mediators |
Q60934712 | The Biological Role of Klotho Protein in the Development of Cardiovascular Diseases |
Q64116201 | The Cardioprotective Effects of Remote Ischemic Conditioning in a Rat Model of Acute Myocardial Infarction |
Q41660449 | The Future Challenge of Reactive Oxygen Species (ROS) in Hypertension: From Bench to Bed Side |
Q55274551 | The HER2 inhibitor lapatinib potentiates doxorubicin-induced cardiotoxicity through iNOS signaling. |
Q37056719 | The Iroquois Homeobox Gene Irx2 Is Not Essential for Normal Development of the Heart and Midbrain-Hindbrain Boundary in Mice |
Q37375441 | The NO/ONOO-cycle as the central cause of heart failure |
Q37091191 | The complex role of iNOS in acutely rejecting cardiac transplants |
Q50067242 | The coxsackie-adenovirus receptor induces an inflammatory cardiomyopathy independent of viral infection |
Q28587676 | The homeodomain transcription factor Irx5 establishes the mouse cardiac ventricular repolarization gradient |
Q33961915 | The role of NOS in heart failure: lessons from murine genetic models |
Q33582810 | The valosin-containing protein is a novel mediator of mitochondrial respiration and cell survival in the heart in vivo |
Q38813230 | Translational neurocardiology: preclinical models and cardioneural integrative aspects |
Q37200527 | Vagus nerve stimulation in experimental heart failure |
Search more.